Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo
Artwork

Content provided by Information Technology and Innovation Foundation (ITIF) — The Leading Think Tank for Science and Tech Policy, Information Technology, Innovation Foundation (ITIF) — The Leading Think Tank for Science, and Tech Policy. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Information Technology and Innovation Foundation (ITIF) — The Leading Think Tank for Science and Tech Policy, Information Technology, Innovation Foundation (ITIF) — The Leading Think Tank for Science, and Tech Policy or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.
Player FM - Podcast App
Go offline with the Player FM app!

mRNA and the Future of Personalized Medicine, With Andrew Geall and Deborah Barbara

27:31
 
Share
 

Manage episode 490294516 series 2676306
Content provided by Information Technology and Innovation Foundation (ITIF) — The Leading Think Tank for Science and Tech Policy, Information Technology, Innovation Foundation (ITIF) — The Leading Think Tank for Science, and Tech Policy. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Information Technology and Innovation Foundation (ITIF) — The Leading Think Tank for Science and Tech Policy, Information Technology, Innovation Foundation (ITIF) — The Leading Think Tank for Science, and Tech Policy or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

Continued innovation and investment is vital to maintaining the U.S.'s leadership in the biopharma sector. Rob and Jackie sit down with Andrew Geall, Chief Development Officer at Replicate Bioscience, and Deborah Barbara, strategic advisor to Primrose Bio, to discuss the development and potential of mRNA as the fourth pillar of pharmaceutical innovation.

Mentioned

Related

  continue reading

101 episodes

Artwork
iconShare
 
Manage episode 490294516 series 2676306
Content provided by Information Technology and Innovation Foundation (ITIF) — The Leading Think Tank for Science and Tech Policy, Information Technology, Innovation Foundation (ITIF) — The Leading Think Tank for Science, and Tech Policy. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Information Technology and Innovation Foundation (ITIF) — The Leading Think Tank for Science and Tech Policy, Information Technology, Innovation Foundation (ITIF) — The Leading Think Tank for Science, and Tech Policy or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://staging.podcastplayer.com/legal.

Continued innovation and investment is vital to maintaining the U.S.'s leadership in the biopharma sector. Rob and Jackie sit down with Andrew Geall, Chief Development Officer at Replicate Bioscience, and Deborah Barbara, strategic advisor to Primrose Bio, to discuss the development and potential of mRNA as the fourth pillar of pharmaceutical innovation.

Mentioned

Related

  continue reading

101 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play